RICHH: Rural Intervention for Caregivers' Heart Health

Sponsor
Debra Moser (Other)
Overall Status
Recruiting
CT.gov ID
NCT03068390
Collaborator
National Institute of Nursing Research (NINR) (NIH)
280
1
2
65.8
4.3

Study Details

Study Description

Brief Summary

The investigators are testing a two-group, randomized, controlled trial with 280 primary caregivers of adult patients with a chronic illness to test the efficacy of the Rural Intervention for Caregivers' Heart Health (RICHH). Immediate (4-month) and long-term (12-month) effects of the RICHH intervention on CVD risk factors, self-management behaviors, and depressive symptoms will be compared to usual care. The investigators also will test the moderating effect of gender on intervention outcomes, given the many differences between male and female caregivers.

Specific Aim 1: To determine effects of the RICHH intervention on the primary outcomes of CVD risk factors (i.e., lipid profile, body mass index, and blood pressure) at 4 and 12 months.

Hypotheses 1: The intervention group will have better lipid profile, body mass index, and blood pressure outcomes than the usual care group at 4 and 12 months.

Specific Aim 2: To determine effects of the RICHH intervention on self-management behaviors (i.e., diet quality, physical activity level, and self-report adherence to specific CVD health behaviors).

Hypotheses 2: The intervention group will have better diet quality, higher physical activity levels, and better adherence to specific CVD health behaviors than the usual care group at 4 and 12 months.

Specific Aim 3: To determine effects of RICHH on depressive symptoms at 4 and 12 months.

Hypotheses 3: Caregivers receiving the intervention will have lower levels of depressive symptoms than caregivers receiving usual care at 4 and 12 months.

Specific Aim 4: To evaluate whether intervention effects on outcomes will differ by caregivers' gender.

Hypotheses 4: Effects will be stronger for male compared to female caregivers at 4 and 12 months.

Impact: The proposed study will have a substantial impact on caregivers' cardiovascular health and quality of life because it will provide needed CVD risk prevention, and health promotion to rural caregivers living in distressed environments where CVD risk reduction and self-management is difficult. The intervention holds the potential to produce major improvements in health among caregivers living in rural environments in the US.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: RICHH Intervention
  • Behavioral: Usual care
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
280 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
2 group randomized controlled trial2 group randomized controlled trial
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Rural Intervention for Caregivers' Heart Health (RICHH)
Actual Study Start Date :
Feb 24, 2017
Anticipated Primary Completion Date :
Aug 21, 2022
Anticipated Study Completion Date :
Aug 21, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: RICHH Intervention

The RICHH intervention is an educational-behavioral and counseling intervention that promotes caregivers' knowledge, skills and motivation to engage in CVD risk reduction. The intervention is delivered individually to caregivers in their homes using video-conferencing technology on mini-iPads that we provide for all participants. Participants keep the mini-iPads at the end of the study. The program consists of 12 weekly sessions [30-45 minutes] followed by 8 bi-weekly [every other week] booster sessions and 6 monthly booster sessions that will be held at the caregivers' preferred times using a video conferencing program. A cardiac psychiatric advanced practice nurse certified cognitive behavioral therapy will deliver the intervention.

Behavioral: RICHH Intervention
Whole health cardiovascular disease (CVD) self-care risk reduction intervention

Active Comparator: Usual care

The usual care control group will receive an attention placebo intervention in which the caregivers will receive mini-iPads loaded with Caregiver and CVD risk reduction pamphlets in PDF format along with the associated links from the American Heart Association. Because the investigators may identify CVD risk factors in baseline testing in participants who do not know they have them, it would be unethical not to provide at least usual care for these. Thus, all individuals enrolled in the study and in whom the investigators identify CVD risk factors will receive referral to a primary care provider for management of the CVD risk factors identified.

Behavioral: Usual care
Referral to primary care provider

Outcome Measures

Primary Outcome Measures

  1. Change in Lipid Profile Derived from point-of-care testing [Baseline, 4 and 12 months]

    lipid profile from point-of-care testing

  2. Change in Body Mass Index (kg/m2) calculated from height and weight [Baseline, 4 and 12 months]

    body mass index calculated from height and weight

  3. Change in Blood Pressure in mmHg [Baseline, 4 and 12 months]

    blood pressure

Secondary Outcome Measures

  1. Change in Diet Quality measured by the Food Frequency Questionnaire [Baseline, 4 and 12 months]

    diet quality

  2. Change in Depressive Symptoms [Baseline, 4 and 12 months]

    depressive symptoms measured using PHQ-9

  3. Change in Physical Activity Level (steps per 24 hours) measured by actigraphy [Baseline, 4 and 12 months]

    physical activity levels assessed using Withings actigraph

  4. Change in Adherence measured using the Specific Adherence Scale score from Medical Outcomes Study [Baseline, 4 and 12 months]

    adherence using Specific Adherence Scale from Medical Outcomes Study

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • primary family rural caregiver of patients with chronic illnesses

  • provided care for the patient for > 6 months

  • no cognitive impairment that would preclude understanding the consent process

Exclusion Criteria:
  • chronic drug abuse

  • current active cancer

  • any physical or emotional impairment that limits participants' abilities to engage in self-management or that is likely to result in needing a caregiver in the next 12 months.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Kentucky Lexington Kentucky United States 40535

Sponsors and Collaborators

  • Debra Moser
  • National Institute of Nursing Research (NINR)

Investigators

  • Principal Investigator: Debra K Moser, PhD, University of Kentucky

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Debra Moser, Sponsor/PI, University of Kentucky
ClinicalTrials.gov Identifier:
NCT03068390
Other Study ID Numbers:
  • 1R01NR016824
  • 1R01NR016824
First Posted:
Mar 1, 2017
Last Update Posted:
Oct 28, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Oct 28, 2021